For health professionals

This page gathers NPS MedicineWise's resources on abdominal imaging. 

Ankle and knee sprains can be accurately diagnosed without imaging in most cases. This program reviews diagnosis and management of these injuries.

Like warfarin, non-vitamin K antagonist oral anticoagulants (NOACs) are no longer ‘new’. Knowing similarities and differences between anticoagulants is key to their safe and effective use. 

Anxiety disorders are common, but there are effective treatments

Asthma is a chronic disease that requires accurate diagnosis, regular treatment and review.

New asthma guideline recommendations may affect how Australians manage their mild asthma.

High blood pressure is a frequently managed problem in Australian general practice. Having constantly high pressure can lead to an increased risk of heart and blood vessel problems and kidney disease. Find out more about how this risk factor can be managed.

In 2013, COPD was the fifth leading cause of death in Australia. This program reviews the role of spirometry in diagnosis, and the stepwise management of COPD. 

Chronic pain is a major cause of distress and disability in the community. This program outlines best practice in the use of medicines and non-pharmacological strategies to manage pain.

Understanding the options available to manage changed behaviour in this complex condition

Depression is a common problem in primary care. This program reviews a range of approaches to the management of depression.

When assessing the need for head imaging, consider potential benefits and harms to avoid inappropriate imaging and to minimise the risk of harms.

This program offers practical tools and strategies to improve quality of life for patients with osteoarthritis

Providing reassurance, encouraging activity and reducing reliance on imaging

Gastro-oesophageal reflux disease (GORD) is common and often treated successfully with proton pump inhibitors (PPIs). Guidelines recommend trying to step down or stop these medicines once symptoms are controlled.

The use of statins continues to play an important role in the management of absolute cardiovascular risk. These medicines are generally well tolerated and can be used long-term in many people.

Finding a balance between when to test, what to test and how to treat

Medicinal cannabis products are treated and regulated as medicines in Australia. Find out more about prescribing, dispensing and taking them.

Neuropathic pain is caused by a lesion or disease of the somatosensory nervous system. Find out more about accurate diagnosis and optimal management of this challenging condition.

Opioid medicines in chronic non-cancer pain – balancing opioid-related harm with effective pain management and quality of life

Osteoporosis is under-recognised and undertreated in Australia. This program examines targeted investigation and treatment.

Codeine is  only available on prescription in Australia from 1 February 2018. Find out more about how health professionals and consumers can manage pain without over-the-counter codeine. 

From 1 October 2021 access to nicotine vaping products will require a prescription.

Antibiotic resistance is an urgent global health issue. This program aims to reduce the inappropriate use of antibiotics in the community.

Rheumatoid arthritis affects around 2% of Australians, and has major effects on quality of life. Find out more about its diagnosis and management.

NPS MedicineWise is working with the Australian Government Department of Health to provide information and phone line support as COVID-19 vaccines are administered across Australia.

Diabetes is progressive and patients eventually need more than one medicine to maintain blood glucose control. This program reviews the evidence on sulfonylureas and other agents.